These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Histological changes after the use of mycophenolate mofetil in autoimmune hepatitis. Brunt EM; Di Bisceglie AM Hum Pathol; 2004 Apr; 35(4):509-12. PubMed ID: 15116334 [TBL] [Abstract][Full Text] [Related]
25. Diagnosis and therapy of autoimmune hepatitis. Granito A; Muratori P; Ferri S; Pappas G; Quarneti C; Lenzi M; Bianchi FB; Muratori L Mini Rev Med Chem; 2009 Jun; 9(7):847-60. PubMed ID: 19519509 [TBL] [Abstract][Full Text] [Related]
26. Second-line Agents in Pediatric Patients With Autoimmune Hepatitis: A Systematic Review and Meta-analysis. Zizzo AN; Valentino PL; Shah PS; Kamath BM J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):6-15. PubMed ID: 28644343 [TBL] [Abstract][Full Text] [Related]
27. A review of the utility of tacrolimus in the management of adults with autoimmune hepatitis. Hanouneh M; Ritchie MM; Ascha M; Ascha MS; Chedid A; Sanguankeo A; Zein NN; Hanouneh IA Scand J Gastroenterol; 2019 Jan; 54(1):76-80. PubMed ID: 30650311 [TBL] [Abstract][Full Text] [Related]
28. Nonstandard drugs and feasible new interventions for autoimmune hepatitis: part I. Czaja AJ Inflamm Allergy Drug Targets; 2012 Oct; 11(5):337-50. PubMed ID: 22563779 [TBL] [Abstract][Full Text] [Related]
29. Autoimmune hepatitis in patients with multiple sclerosis: The role of immunomodulatory treatment. Rigopoulou EI; Gyftaki S; Arvaniti P; Tsimourtou V; Koukoulis GK; Hadjigeorgiou G; Dalekos GN Clin Res Hepatol Gastroenterol; 2019 Jun; 43(3):e25-e32. PubMed ID: 30594597 [TBL] [Abstract][Full Text] [Related]
30. Protocol of a prospective study for the combination treatment of Shu-Gan-jian-Pi decoction and steroid standard therapy in autoimmune hepatitis patients. Chi XL; Xiao HM; Xie YB; Cai GS; Jiang JM; Tian GJ; Shi MJ; Wu SD; Zhao PT; Chen HJ BMC Complement Altern Med; 2016 Dec; 16(1):505. PubMed ID: 27923369 [TBL] [Abstract][Full Text] [Related]
31. Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management. Rizvi S; Gawrieh S Drugs Aging; 2018 Jul; 35(7):589-602. PubMed ID: 29971609 [TBL] [Abstract][Full Text] [Related]
32. Drug choices in autoimmune hepatitis: part B--Nonsteroids. Czaja AJ Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):617-35. PubMed ID: 23061712 [TBL] [Abstract][Full Text] [Related]
33. [Diagnosis and treatment of autoimmune hepatitis]. Verwer BJ; Bouma G; Bloemena E; Schreuder TC; Mulder CJ; van Nieuwkerk KM Ned Tijdschr Geneeskd; 2009; 153():A247. PubMed ID: 19900315 [TBL] [Abstract][Full Text] [Related]
34. Diagnosis and management of autoimmune hepatitis. Czaja AJ Clin Liver Dis; 2015 Feb; 19(1):57-79. PubMed ID: 25454297 [TBL] [Abstract][Full Text] [Related]
39. Mycophenolate mofetil as an alternative treatment for autoimmune hepatitis. Park SW; Um SH; Lee HA; Kim SH; Sim Y; Yim SY; Seo YS; Ryu HS Clin Mol Hepatol; 2016 Jun; 22(2):281-5. PubMed ID: 27246353 [TBL] [Abstract][Full Text] [Related]
40. A single center review of the use of mycophenolate mofetil in the treatment of autoimmune hepatitis. Hlivko JT; Shiffman ML; Stravitz RT; Luketic VA; Sanyal AJ; Fuchs M; Sterling RK Clin Gastroenterol Hepatol; 2008 Sep; 6(9):1036-40. PubMed ID: 18586559 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]